Mauna Kea Technologies Reports Third Quarter and First Nine Months of 2021 Sales

Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform

Related Keywords

China ,United States ,Paris ,France General ,France ,Robertl Gershon ,Thomas Grojean ,Mauna Kea Techonologie ,Mike Piccinino ,French Financial Markets Authority Autorit ,Regulatory News ,Kea Technologies ,Nine Months ,Chief Executive Officer ,Mauna Kea ,First Nine Months ,Systems Sold ,System Placements ,Cellvizio System ,Mauna Kea Technologies ,Registration Document ,French Financial Markets Authority ,Cap Investor Relations ,Mauna ,Technologies ,Reports ,Third ,Quarter ,First ,Line ,Months ,021 ,Sales ,